Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
This is an open-label, non-randomized, clinical study to evaluate the drug interaction between itraconazole, rifampin or Cocktail and JMKX001899 in healthy subjects. A total of three cohorts of 72 healthy subjects were planned to be enrolled in each cohort.
Solid Tumor, Adult
DRUG: JMKX001899|DRUG: Itraconazole|DRUG: Midazolam|DRUG: Rifampin|DRUG: dextromethorphan|DRUG: Rosuvastatin|DRUG: digoxin
maximum concentrations (Cmax ) for plasma, approximately 3 days after first dose|area under the curve from time 0 to infinity(AUC0-inf) for plasma, approximately 3 days after first dose|area under the curve from time 0 to the last time point (AUC0-t) for plasma, approximately 3 days after first dose
This is an open-label, non-randomized, clinical study to evaluate the drug interaction between itraconazole, rifampin or Cocktail and JMKX001899 in healthy subjects. A total of three cohorts of 72 healthy subjects were planned to be enrolled in each cohort.